Do novel inflammation biomarkers arising from routine complete blood count play a role in patients with systemic lupus erythematosus?

Compared to healthy controls the CBC-based SIIB investigated are significantly increased in SLE patients. However, SIIB do not appear to be useful in managing SLE clinically. Nevertheless, we confirm that higher ANA titers can predict flares of SLE.